Effect of Calcium Channel Blockers on Lower Urinary Tract Symptoms: A Systematic Review

Background. Numerous medications are known to be associated with the development of lower urinary tract symptoms (LUTS). One such medication group is calcium channel blockers (CCB). Objective. To critically examine the literature regarding the involvement of CCB in manifestation of LUTS in humans. Methods. A systematic literature search was conducted on PubMed, SciELO, Scopus, and OpenGrey databases to find all potentially relevant research studies before August 2016. Results. Five studies met the inclusion criteria and were included in this review. Three out of five studies stated that CCB were involved in either precipitation or exacerbation of LUTS. As for the remaining two studies, one study found out that only the monotherapy of CCB was associated with increased prevalence of nocturia and voiding symptoms in young females, whereas the other study reported an inverse association of CCB with LUTS. The methodological quality of studies was considered high for four studies and low for one study. Conclusion. Healthcare providers should make efforts for an earlier identification of the individuals at risk of LUTS prior to the commencement of CCB therapy. Moreover, patients should be counselled to notify their healthcare provider if they notice urinary symptoms after the initiation of CCB

Reverse-phase chromatographic determination and intrinsic stability behavior of 5-[(4-chlorophenoxy)methyl]-1,3,4-oxadiazole-2-thiol

The study describes the development and preliminary validation of a simple reverse phase chromatographic method for determination of a novel drug candidate, 5-[(4-chlorophenoxy)methyl]-1,3,4-oxadiazole-2-thiol (OXCPM), in bulk and stressed solution, in order to find out the intrinsic stability behavior of the compound. Isocratic elution was carried out at a flow rate of 1.0 mL min–1 through a Promosil C18 column maintained at 25 °C, using the mobile phase comprising acetonitrile and aqueous o-H3PO4 (pH 2.67) (1:1, V/V). Detection was performed at 258 nm. The response of the detector was linear in a concentration range of 1.25–50.00 µg mL–1 with the correlation coefficient of 0.9996 ± 0.0001. Cumulative intra-day, inter-day and inter-instrument accuracy (99.5 ± 1.0, 100.2 ± 1.0 and 100.3 ± 0.4 %, resp.) with RSD less than 5 % indicated that the method was accurate and precise. The resolution and selectivity factor (>2 and >1, resp.), particularly in copper metal- and dry-heat-stress solutions, depicted the selectivity of the method. OXCPM remained stable under hydrolytic (acidic and neutral pH, ≤ 37 °C), photolytic and moist heat stress conditions. Under alkaline conditions (hydrolytic and photolytic), polar products were formed and eluted very fast through the column (tR < 3.75 min). At room temperature, the compound was susceptible to oxidation by hydrogen peroxide and transition metals. The ionogram of most of the stress solutions indicated the presence of a product having m/z 256, which may be a result of N- or S- methylation or -SH oxidation. The results of the study indicate that the method is selective, sensitive and suitable to be used for determination of OXCPM in bulk and under stress conditions

Evaluating the antidiabetic and antioxidant properties of 5- benzyl-1,3,4-oxadiazole-2-thiol

Purpose: To evaluate 5-Benzyl-1,3,4-oxadiazole-2-thiol (OXPA) for antidiabetic and antioxidant properties. Methods: Antidiabetic activity was evaluated using three in vitro models, glucose uptake by yeast cells, alpha amylase inhibition assay and hemoglobin glycosylation inhibition assays. Antioxidant potential was determined by DPPH radical scavenging, reducing power and lipid peroxidation assays. Results: OXPA showed antidiabetic activity in all the three models. The activity of the compound was comparable with that of metronidazole in glucose uptake by yeast cells, but the alpha amylase inhibition activity of the compound was slightly lower than that of acarbose, whereas the hemoglobin glycosylation inhibition activity of the compound was higher than that of vitamin E. DPPH free radical and hydrogen peroxide scavenging activity of the compound was comparable with that of vitamin C. In reducing power assay, the activity of the compound was lower than that of vitamin C (p &gt; 0.05). Conclusion: The results of antidiabetic and antioxidant activity indicate that OXPA may be a drugcandidate for treating both diabetes and its associated oxidative stress

Bryophyllum pinnatum: BOTANICAL DESCRIPTION, VERNACULAR NAMES, PARTS USED, TRADITIONAL USES, PHYTOCHEMICAL AND PHRMACOLOGICAL ACTIVITIES

Bryophyllum pinnatum (Family: Crassulaceae) is a traditional herb that has widely been used for removal of kidney stones and is found to possess a number of pharmacological activities such as antiviral, antipyretic, antimicrobial, anti-inflammatory, antitumor, hypocholesterolemic, antioxidant, diuretic, antiulcer, styptic, antidiabetic, astringent, antiseptic, antilithic, cough suppressant, anticancer, antihypertensive, fungitoxic and uterine relaxant. The plant contains flavonoids, tannins, anthocyanins, glycosides, alkaloids, phenols, bufadienolides, saponins, coumarins, carotenoids, sitosterols, quinines, tocopherol and lectins. The flavonoids rutin, quercetin, luteolin and luteolin 7-O-&beta;-d-glucoside detected in the plant might be a responsible factor for the anti-inflammatory effect. Diuretic and antioxidant activity of the plant could be responsible for its wide use against urolithiasis. Anthocyanidines could be responsible for the antimicrobial activity of the plant. Kaempferol 3-O-&alpha;-l-arabinopyranosyl (1&rarr;2) &alpha;-l-rhamnopyranoside) and two other polar flavonoids (quercetin 3-O-&alpha;-l- arabinopyranosyl (1&rarr;2) &alpha;-l-rhamnopyranoside and 4&prime;, 5-dihydroxy-3&prime;, 8-dimethoxyflavone 7-O-&beta;-d- glucopyranoside) are responsible for the antileshmanial activity. Bufodienolides are found to have cytotoxic property and hence might be responsible for the anticancer effect. The present study is undertaken to update and ease the researchers to get a comprehensive summary of the plant regarding its botanical description, common name, parts used, traditional uses, phytochemical evaluation and pharmacological activities